Global Health’s Dirty Secret: Rich Countries Get Good Medicine, the Poor Sometimes Get Poison

September 11, 2023

(New York Times) – The problem lies mainly in regulatory inequities between rich and poor nations. Developed countries have well-funded regulators keeping an eye on the safety and quality of drugs. India’s output, however, is overseen by its Central Drugs Standard Control Organization, an opaque agency that has long faced allegations of mismanagement and corruption. Many developing nations don’t have the resources to properly vet imported medicines. (Read More)